ATE526980T1 - Zusammensetzungen und verfahren zur heilung von nervengeweben - Google Patents

Zusammensetzungen und verfahren zur heilung von nervengeweben

Info

Publication number
ATE526980T1
ATE526980T1 AT99955594T AT99955594T ATE526980T1 AT E526980 T1 ATE526980 T1 AT E526980T1 AT 99955594 T AT99955594 T AT 99955594T AT 99955594 T AT99955594 T AT 99955594T AT E526980 T1 ATE526980 T1 AT E526980T1
Authority
AT
Austria
Prior art keywords
healing
compositions
methods
nervous tissue
present
Prior art date
Application number
AT99955594T
Other languages
English (en)
Inventor
Perry F Bartlett
Lynne Hartley
Mark Pilizzotto
Trevor Kilpatrick
Frank Kontgen
Jason Coonan
Ursula Greferath
Andrew W Boyd
Mirella Dottori
Mary Galea
George Paxinos
Mark Murphy
Original Assignee
Inst Medical W & E Hall
Queensland Inst Med Res
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Medical W & E Hall, Queensland Inst Med Res, Univ Melbourne filed Critical Inst Medical W & E Hall
Application granted granted Critical
Publication of ATE526980T1 publication Critical patent/ATE526980T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processing Of Meat And Fish (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99955594T 1998-10-27 1999-10-27 Zusammensetzungen und verfahren zur heilung von nervengeweben ATE526980T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP6748A AUPP674898A0 (en) 1998-10-27 1998-10-27 A method of treatment
PCT/AU1999/000931 WO2000024413A1 (en) 1998-10-27 1999-10-27 A method of treatment

Publications (1)

Publication Number Publication Date
ATE526980T1 true ATE526980T1 (de) 2011-10-15

Family

ID=3810964

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99955594T ATE526980T1 (de) 1998-10-27 1999-10-27 Zusammensetzungen und verfahren zur heilung von nervengeweben

Country Status (6)

Country Link
US (2) US7341997B2 (de)
EP (1) EP1133309B1 (de)
AT (1) ATE526980T1 (de)
AU (1) AUPP674898A0 (de)
CA (1) CA2346219C (de)
WO (1) WO2000024413A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887674B1 (en) 1998-04-13 2005-05-03 California Institute Of Technology Artery- and vein-specific proteins and uses therefor
US6864227B1 (en) 1998-04-13 2005-03-08 California Institute Of Technology Artery-and vein-specific proteins and uses therefor
AUPP674898A0 (en) 1998-10-27 1998-11-19 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment
US7381410B2 (en) 2003-03-12 2008-06-03 Vasgene Therapeutics, Inc. Polypeptide compounds for inhibiting angiogenesis and tumor growth
EP1606305A4 (de) 2003-03-12 2009-06-24 Vasgene Therapeutics Inc Nukleinsäureverbindungen für die inhibierung von angiogenese und tumorwachstum
DK1730196T3 (da) 2004-03-12 2011-03-28 Vasgene Therapeutics Inc EphB4-bindende antistoffer til inhibering af antiogenese og tumorvækst
CN101072797B (zh) 2004-03-12 2012-05-09 瓦斯基因治疗公司 结合ephb4、抑制血管发生和肿瘤生长的抗体
CA2579352A1 (en) * 2004-09-08 2006-03-16 The University Of Queensland Treating gliosis, glial scarring, inflammation or inhibition of axonal growth in the nervous system by modulating eph receptor
AU2005282217B2 (en) * 2004-09-08 2012-05-31 The University Of Melbourne Treating gliosis, glial scarring, inflammation or inhibition of axonal growth in the nervous system by modulating eph receptor
CA2581423A1 (en) 2004-09-23 2006-03-30 Vasgene Therapeutics, Inc. Polipeptide compounds for inhibiting angiogenesis and tumor growth
CA2696164C (en) 2007-08-13 2018-06-12 Vasgene Therapeutics, Inc. Cancer treatment using humanized antibodies that bind to ephb4
NZ611428A (en) 2010-12-08 2015-07-31 Stemcentrx Inc Novel modulators and methods of use
JP2016540826A (ja) 2013-11-04 2016-12-28 ファイザー・インク 抗ｅｆｎａ４抗体−薬物コンジュゲート
JP6877419B2 (ja) * 2015-10-27 2021-05-26 ザ ユニバーシティー オブ クイーンズランド 治療の方法およびそのために有用な剤
CN111259868B (zh) * 2020-03-10 2023-12-12 以萨技术股份有限公司 基于卷积神经网络的逆行车辆检测方法、系统及介质

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795734A (en) * 1994-09-19 1998-08-18 President And Fellows Of Harvard College EPH receptor ligands, and uses related thereto
EP0787148B1 (de) * 1994-10-27 2004-04-07 Genentech, Inc. Neurotrophischer al-1 faktor, einer ligand verwant mit dem eph tyrosine kinase receptor
US6057124A (en) * 1995-01-27 2000-05-02 Amgen Inc. Nucleic acids encoding ligands for HEK4 receptors
WO1996026958A2 (en) * 1995-02-27 1996-09-06 President And Fellows Of Harvard College Eph RECEPTOR LIGAND ELF-2
EP0842272A4 (de) * 1995-07-20 2002-03-06 Amrad Operations Pty Ltd Neuartige rezeptorliganden und genetische sequenzen, welche für diese kodieren
EP1019728A1 (de) * 1995-10-13 2000-07-19 Mount Sinai Hospital Verfahren zur aktivierung eines neuen ligand-regulierten wegs
AUPP674898A0 (en) * 1998-10-27 1998-11-19 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment
CA2579352A1 (en) 2004-09-08 2006-03-16 The University Of Queensland Treating gliosis, glial scarring, inflammation or inhibition of axonal growth in the nervous system by modulating eph receptor

Also Published As

Publication number Publication date
CA2346219C (en) 2011-12-20
CA2346219A1 (en) 2000-05-04
EP1133309A1 (de) 2001-09-19
EP1133309A4 (de) 2004-09-01
AUPP674898A0 (en) 1998-11-19
WO2000024413A1 (en) 2000-05-04
US7897570B2 (en) 2011-03-01
US20080255044A1 (en) 2008-10-16
US7341997B2 (en) 2008-03-11
EP1133309B1 (de) 2011-10-05
US20050181981A1 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
ATE526980T1 (de) Zusammensetzungen und verfahren zur heilung von nervengeweben
ATE256464T1 (de) Verfahren zur bekämpfung infektiöser krankheiten unter verwendung dikationischer bis-benzimidazole
ATE519451T1 (de) Implantat zur behandlung von bändern und sehnen
DE69829336D1 (de) Vorrichtung und Verfahren zur Behandlung von Körpergewebe
DE69535498D1 (de) Verfahren zur behandlung vaskulärer kopfschmerzen
SE9803710D0 (sv) Use of certain drugs for treating nerve root injury
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
DE69942702D1 (de) Zusammenstellungen und methoden zur behandlung der alzheimerschen krankheit, schäden des zentralnervensystems und entzündlichen erkrankungen
BRPI0006634B8 (pt) composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
BR9602485A (pt) Método para o tratamento da doença de Parkinson composição farmacêutica primeira composição farmacêutica e método para a obtenção de efeito antiParkinson
PL336788A1 (en) Probucol monoesters in treating circulatory system and inflammatory diseases
EP0792156A4 (de) Verfahren zur vorbeugung oder behandlung von vaskulären hämorragien und der alzheimerischen krankheit
ATE207356T1 (de) Verwendung von tiagabin zur behandlung von schlafstörungen
DE69823852D1 (de) Verfahren zur förderung des haarwuchses und entwicklung des haarsystems
ATE403437T1 (de) Lfa-1 antagonisten und tnf-alpha antagonisten zur behandlung von rheumatoiden arthritis
ATE411016T1 (de) Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten
ATE555803T1 (de) Verwendung von osteopontin zur behandlung und/oder vorbeugung von neurologischen erkrankungen
ATE362374T1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE138567T1 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
ATE422357T1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
ATE260653T1 (de) Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
ATA15697A (de) Vorrichtung zur gewinnung bzw. behandlung von fasern und faserprodukten
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties